Advertisement

Ethambutol Tablets

[11 September 2014]

Products Affected - Description

Ethambutol tablets, G&W Laboratories
100 mg tablets, 100 count, NDC 68850-0004-01 -- discontinued
400 mg tablets, 100 count, NDC 68850-0005-01 -- discontinued
 
Ethambutol tablets, VersaPharm, Inc.
100 mg tablets, 100 count (NDC 61748-0011-01)
400 mg tablets, 60 count (NDC 61748-0014-06)
400 mg tablets, 90 count (NDC 61748-0014-09)
400 mg tablets, 100 count (NDC 61748-0014-01)
400 mg tablets, 100 count, unit dose (NDC 61748-0014-11)
400 mg tablets, 1000 count (NDC 61748-0014-10)
 
Ethambutol tablets, Teva Pharmaceuticals
400 mg tablets, 100 count (NDC 00555-0923-02)
 
Myambutol tablets, X-Gen Pharmaceuticals
100 mg tablets, 100 count (NDC 68850-0010-01)

Reason for the Shortage

  • VersaPharm states the reason for the shortage is change in manufacturing facility.
  • X-Gen could not provide a reason for the shortage.
  • G&W Laboratories discontinued ethambutol tablets in mid-April 2013.  

Available Products

Ethambutol tablets, Lupin Pharmaceuticals
100 mg tablets, 100 count (NDC 68180-0280-01)
400 mg tablets, 100 count (NDC 68180-0281-01)
 
Myambutol tablets, X-Gen Pharmaceuticals
400 mg tablets, 100 count (NDC 68850-0012-01)
400 mg tablets, 100 count, unit dose (NDC 68850-0012-02)

Estimated Resupply Dates

  • VersaPharm has all ethambutol tablets temporarily unavailable and the company cannot estimate a release date.
  • Teva has ethambutol 400 mg tablets on back order and the company cannot estimate a release date.
  • X-Gen has Myambutol 100 mg tablets on long-term back order and the company cannot estimate a release date.

Related Shortages

Updated

September 11, 2014; July 9, 2014; May 16, 2014; March 12, 2014; January 8, 2014; October 25, 2013; August 9, 2013; May 28, 2013; April 24, 2013; March 14, 2013; February 13, 2013; December 7, 2012; December 6, 2012, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement